Although it is known that there are some pharmacological differences between the structurally similar barbiturates, the underlying mechanism of action remains unclear. We have compared the effects of thiopental, thiamylal and phenobarbital on both voltage-gated calcium channels (VGCC) and N-methyl-D-aspartate (NMDA) were reduced equally with thiamylal and thiopental, thiamylal was more effective in attenuating the increase in [Ca 2; ] i produced by NMDA receptor activation than thiopental. We conclude that the depressant effects of barbiturates on both VGCC and NMDA receptors varied between agents. Differential inhibition of both VGCC and NMDA receptors may determine the pharmacological properties of barbiturates and their ability to protect neurones against ischaemia. (Br.
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Summary
Although it is known that there are some pharmacological differences between the structurally similar barbiturates, the underlying mechanism of action remains unclear. We have compared the effects of thiopental, thiamylal and phenobarbital on both voltage-gated calcium channels (VGCC) and N-methyl-D-aspartate (NMDA) receptors in rat hippocampal slices by determining changes in intracellular calcium ([Ca 2; ] i ). Experiments were performed in adult rat hippocampal slices perfused with Krebs solution (37ЊC). Concentrations of [Ca 2; ] i in the pyramidal cell layer of the CA1 region were measured using a calcium indicator dye, fura-2. To activate VGCC and NMDA receptors, slices were exposed to K were reduced equally with thiamylal and thiopental, thiamylal was more effective in attenuating the increase in [Ca 2; ] i produced by NMDA receptor activation than thiopental. We conclude that the depressant effects of barbiturates on both VGCC and NMDA receptors varied between agents. Differential inhibition of both VGCC and NMDA receptors may determine the pharmacological properties of barbiturates and their ability to protect neurones against ischaemia. (Br. J. Anaesth. 1998; 81: 932-939) Keywords : hypnotics barbiturate, phenobarbital; anaesthetics i.v., thiamylal; anaesthetics i.v., thiopental; receptors, amino acid; ions, calcium; ions, ion channels, voltage-gated Barbiturates are central nervous system (CNS) depressants and clinically used as sedatives, hypnotics, anticonvulsants and anaesthetics. At the molecular level, all barbiturates can potentiate GABAergic neurotransmission, and this action is thought to mediate some of the behavioural changes mentioned above. 1 However, there are some pharmacological differences between the structurally similar barbiturates. For example, phenobarbital is an anticonvulsant that produces minimal sedation at clinically effective doses, whereas pentobarbital profoundly depresses the CNS at anticonvulsive doses. 2 In contrast, evidence has emerged that the ability of barbiturates to protect neurones against ischaemia varies, 3 while they all seem homogeneous in their capacity to reduce cerebral metabolic rate. Thus the GABA hypothesis does not explain the differences in pharmacological profiles of the various barbiturates. Presumably, these differences could be caused by the actions of these drugs on other target sites.
By determining intracellular calcium ([Ca ] i ) responses in brain slice preparations, we observed that thiopental inhibited both voltage-gated calcium channels (VGCC) and NMDA receptors and in addition, its inhibitory effect on NMDA receptors represented regional differences 4 in accordance with the regionally specific protection produced by thiopental. 5 6 Thus we hypothesized that the inhibitory effects exhibited by each barbiturate on both VGCC and NMDA receptors may not be equivalent. In this study, we have compared the effects of three barbiturates (thiopental, thiamylal and phenobarbital) on both VGCC and NMDA receptors in rat hippocampal slices. VGCC and NMDA receptors were activated by membrane depolarization with high K ;7 and NMDA, respectively. The activities of VGCC and NMDA receptors were determined by measuring changes in [Ca 2; ] i .
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Materials and methods
This study was approved by the Committee on the Guidelines for Animal Experimentation at Niigata University. Experiments were conducted on hippocampal slices obtained from male Wistar rats, weighing 100-130 g (30-35 days old). The animals were deeply anaesthetized with isoflurane and decapitated. Their brains were removed rapidly and immersed in ice-cold oxygenated Krebs solution containing (mmol litre (DTK-1000, Dosaka, Kyoto, Japan). Hippocampi were isolated from the appropriate sections.
To load fura-2 intracellularly, slices were incubated in oxygenated Krebs solution containing 10 mol litre 91 of the acetoxymethyl ester of fura-2 (fura-2/AM) (Dojindo, Kumamoto, Japan) and 0.1% Pluronic F-127 (Boehringer, La Jolla, CA, USA) for 90 min at 21-23ЊC using an interface chamber. Subsequently, these slices were rinsed twice and reincubated in oxygenated Krebs solution for an additional 20-30 min to allow hydrolysis of the acetoxymethyl ester.
The fura-2 loaded slices were transferred individually into a recording chamber (effective volume 0.30 ml) mounted on the stage of an inverted fluorescence microscope (Diaphot, Nikon, Tokyo, Japan) equipped with a 20 objective, and were superfused continuously with 95% oxygen-5% carbon dioxideequilibrated Krebs solution. The flow rate was 5.5 ml min
91
, and the temperature in the recording chamber was kept at 36.5-37.5ЊC using a heating bath. Concentrations of [Ca 2;  ] i in the pyramidal cell layer of the CA1 region were monitored as the fluorenscence of fura-2, with a microspectrofluorimeter (JASCO CAM-500, Japan Spectroscopic Co. Ltd, Tokyo, Japan), as described previously. 4 Drugs were applied by superfusion. DL-2-amino-5-phosphonovaleric acid (APV), phenobarbital, sodium thiopental, sodium thiamylal and verapamil were added to the bathing media 5 or 10 min before, during and 1 min after high K ; or NMDA application. APV, N-methyl-D-aspartate (NMDA), sodium thiamylal and verapamil hydrochloride were purchased from Sigma Chemical Co. (St Louis, MO, USA). Sodium thiopental was a gift of Tanabe Pharmaceutical Co. (Osaka, Japan). Lanthanum chloride, phenobarbital and tetrodotoxin (TTX) were obtained from Wako Chemical Industries Ltd (Osaka, Japan). -conotoxin GVIA was purchased from RBI (Natick, MA, USA), and -agatoxin-TK was obtained from Peptide Institute Co. (Osaka, Japan).
Data are expressed as mean (SD) and were analysed using either Student's t test or one-way ANOVA. ANOVA was followed by Dunnett's post hoc test for multiple comparisons. P:0.05 was considered statistically significant. . 17 18 However, we found that both verapamil, an L-type VGCC blocker, andagatoxin-TK, a P/Q-type VGCC blocker, partially ] i and is consistent with the observation that -conotoxin GVIA is ineffective under strong depolarization. 19 Barbiturates such as thiopental and pentobarbital are known to block calcium currents in several nonneuronal cell lines, [20] [21] [22] and in neurones. 23 By determining changes in [Ca 2; ] i , we have shown that thiopental, a typical ultra-short acting barbiturate, inhibits VGCC in a concentration-dependent manner in both the hippocampus and cortex. 4 Here we demonstrated that the inhibitory effect of thiamylal on VGCC was almost equipotent with thiopental (fig 2, 3) . Comparing thiopental and thiamylal with the specific VGCC blockers, it became clear that at clinically relevant concentrations (100-400 mol ] i to degrees similar to removal of Ca 2; , suggesting that they must affect multiple VGCC. Given the importance of calcium influx through VGCC in both physiological and pathological conditions, differential inhibition of VGCCs by barbiturates might account in part for the differences in their effects on behavioural changes in addition to their neuroprotective effects. ] i responses can also be used as an indicator to estimate the activities of NMDA receptors. 8 In the presence of Mg ] i after NMDA application may lead to long-term inactivation of NMDA receptors. 26 27 Although it is possible that the increases in [Ca 2; ] i produced by NMDA may be in part caused by membrane depolarization after NMDA receptor activation, we did not systematically separate calcium entry through NMDA receptor-gated calcium channels or VGCC for two reasons. First, the divalent cations used to block VGCC can interact with both the calcium indicator dye fura-2 and the glutamate receptor, 8 ). 28 Thiamylal, an ultra-short acting barbiturate, is considered to be clinically indistinguishable from thiopental. Surprisingly, the inhibitory effect of thiamylal on NMDA receptors was more effective than thiopental. As the increases in [Ca ] i by NMDA receptor activation may in part result from opening of VGCC secondary to membrane depolarization, one can argue that the strong inhibition of the NMDA-induced [Ca . This is in accordance with the observation that inhibition of calcium current by phenobarbital is weaker than that of pentobarbital. 20 Comparison of the inhibitory effects of thiopental and thiamylal on VGCC with phenobarbital, raises the question of whether or not differential inhibition of VGCC contributes to the differences in pharmacological profiles. It is known that Ca 2; influx through VGCC is necessary for triggering the release of neurotransmitters 29 ; one consequence of inhibition of VGCC could be block of Ca 2; entry into presynaptic nerve terminals and inhibition of release of neurotransmitters such as glutamate, resulting in a net reduction of excitatory synaptic transmission. Experiments performed in synaptosomes 30 and SH-SY5Y human neuroblastoma cells 31 have demonstrated that thiopental, at clinically relevant concentrations, can reduce high K ; -evoked neurotransmitter release. In addition to this, examining the interaction between VGCC blockers and anaesthetics revealed that VGCC blockers reduce, while VGCC openers increase anaesthetic requirements. [32] [33] [34] [35] From the above observations, it is conceivable that induction of the anaesthetic state by thiopental and thiamylal may be caused partly by inhibition of VGCC. To establish that VGCC are the target sites for induction of the anaesthetic state, further efforts should be made to understand, under physiologically relevant conditions, what concentrations of barbiturates are needed to reduce Ca 2; entry into presynaptic terminals and the release of neurotransmitters, and whether the decreases in Ca 2; influx and release of neurotransmitters are causally associated in a reduction of postsynaptic membrane excitability.
Results
CHANGES IN [CA
Although barbiturates are known to have a protective effect against cerebral ischaemia, the underlying mechanism(s) remains unclear. 36 Evidence has emerged that combined inhibition of both VGCC and NMDA receptors may have synergistic effects in protecting ischaemic neurones; Rod and Auer 37 have shown that neither nimodipine, a VGCC blocker, nor dizocilpine, an NMDA receptor antagonist, but a combination treatment with both agents protected neurones in a rat model of transient forebrain ischaemia. On the other hand, sigma ligands, such as dextromethorphan, protect neurones against ischaemia 38 39 by a mechanism that has also been related to inhibition of both VGCC and NMDA receptors. 39 40 Thiopental has been shown to inhibit both VGCC and NMDA receptors and its inhibition of NMDA receptors is more effective in the cortex than in the hippocampus. 4 This is in good agreement with the observation that thiopental protects neurones in the cortex but not in the hippocampus. 5 On the basis of these observations, it is rational to speculate that combined inhibition on both VGCC and NMDA receptors could be important in determining the neuroprotective action of barbiturates. As the effect of thiamylal on brain ischaemia is reported rarely, experiments in vivo are necessary to examine if the neuroprotective effect produced by thiamylal is superior to other barbiturates, especially in the hippocampus.
In summary, the effects of barbiturates on both VGCC and NMDA receptors varied between agents. Differential inhibition of both VGCC and NMDA receptors may be factors in determining the diversity of pharmacological properties of barbiturates and their ability to protect neurones against ischaemic damage.
